comparemela.com
Home
Live Updates
Tildrakizumab therapy proves beneficial for Plaque Psoriasis : comparemela.com
Tildrakizumab therapy proves beneficial for Plaque Psoriasis
ITALY: Tildrakizumab was found to be beneficial for up to 36 weeks in treating moderate-to-severe plaque psoriasis, according to a new study published in the Journal of the European Academy of...
Related Keywords
Italy ,
Alessio Gambardella ,
Gaetano Licata ,
Department Of Mental ,
University Of Campania Luigi Vanvitelli ,
Journal Of The European Academy Dermatology ,
European Academy ,
Physical Health ,
Preventive Medicine ,
Campania Luigi Vanvitelli ,
Global Assessment ,
Psoriasis Area ,
Severity Index ,
Biological Drugs ,
Cdlqi ,
Upasi ,
Plaque Psoriasis ,
Quality Of Life ,
Real Life ,
Tildrakizumab ,
Monoclonal Antibody ,
Ermatology ,
comparemela.com © 2020. All Rights Reserved.